Results 161 to 170 of about 16,315 (211)

Plain Language Summary of the Scientific report on azole resistance in Aspergillus spp. [PDF]

EFSA J
europepmc   +1 more source

Azole resistance in <i>Aspergillus</i> isolates from animals or their direct environment (2013-2023): a systematic review. [PDF]

Front Vet Sci
Dieste-Pérez L, Holstege MMC, de Jong JE, Heuvelink AE.   +3 more
europepmc   +1 more source

Azole Resistance in Veterinary Clinical Aspergillus fumigatus Isolates in the Netherlands. [PDF]

Mycopathologia
van Dijk MAM, Buil JB, Tehupeiory-Kooreman M, Broekhuizen MJ, Broens EM, Wagenaar JA, Verweij PE.   +6 more
europepmc   +1 more source

Deletion of <i>RAP1</i> affects iron homeostasis, azole resistance, and virulence in <i>Candida albicans</i>. [PDF]

mSphere
Yang M-C, Huang W-L, Chen H-Y, Lin S-H, Chang Y-S, Tseng K-Y, Lo H-J, Wang I-C, Lin C-J, Lan C-Y.   +9 more
europepmc   +1 more source

Insights into the structure, function, and impact of <i>Candida albicans UPC2</i> gene on azole resistance; a mini-review. [PDF]

Curr Med Mycol
Hoseinnejad A, Mahdizade AH, Erfaninejad M, Kermani F, Ghazanfari M, Arbabi A, Bahreiny SS, Bozorgomid A, Moradi M, Haghani I, Abastabar M.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Azole Resistance in Candida glabrata

Current Infectious Disease Reports, 2016
Candida infections have increased due to the growth and expansion of susceptible patient populations. The azole fluconazole is the most widely prescribed antifungal, but rising rates of clinical resistance among Candida glabrata isolates have greatly limited its utility.
Sarah G Whaley, P David Rogers
exaly   +3 more sources

Emergence of Azole Resistance in Aspergillus

Seminars in Respiratory and Critical Care Medicine, 2015
Resistance to the azole antifungals itraconazole, voriconazole, and posaconazole in Aspergillus species is a growing concern. This is especially alarming for A. fumigatus, where acquired resistance has been documented in patients with invasive disease caused by this species that were exposed to these agents, as well as in azole-naive individuals.
Nathan P, Wiederhold, Thomas F, Patterson   +1 more
openaire   +2 more sources

Assessment of Azole Resistance in Healthcare Facilities

2021
Azole resistance among fungal species has been increasing worldwide in recent years, representing a public health concern in the management of fungal infections. The complex environment of healthcare facilities, where microbial agents, including fungal contamination, are present must be controlled in order to protect susceptible patients. In this study,
Caetano, Liliana Aranha, Costa, Natália, Oliveira, Cátia   +2 more
openaire   +2 more sources

Antifungal drug resistance to azoles and polyenes

The Lancet Infectious Diseases, 2002
There is an increased awareness of the morbidity and mortality associated with fungal infections caused by resistant fungi in various groups of patients. Epidemiological studies have identified risk factors associated with antifungal drug resistance.
Mar, Masiá Canuto, Félix, Gutiérrez Rodero   +1 more
openaire   +2 more sources

Azole resistance inCandida albicans

Medical Mycology, 1984
Two isolates of Candida albicans from chronic mucocutaneous candidosis patients who initially responded to ketoconazole treatment but who later relapsed, have shown an abnormal response to ketoconazole in four out of five systems in vitro and in three animal models of vaginal or systemic infection. They have also shown abnormal resistance to inhibition
J F, Ryley, R G, Wilson, K J, Barrett-Bee   +2 more
openaire   +2 more sources